Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Use of Updated COVID-19 Vaccines 2023-2024 Formula for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices - United States, September 2023.
Regan JJ, Moulia DL, Link-Gelles R, Godfrey M, Mak J, Najdowski M, Rosenblum HG, Shah MM, Twentyman E, Meyer S, Peacock G, Thornburg N, Havers FP, Saydah S, Brooks O, Talbot HK, Lee GM, Bell BP, Mahon BE, Daley MF, Fleming-Dutra KE, Wallace M. Regan JJ, et al. Among authors: havers fp. MMWR Morb Mortal Wkly Rep. 2023 Oct 20;72(42):1140-1146. doi: 10.15585/mmwr.mm7242e1. MMWR Morb Mortal Wkly Rep. 2023. PMID: 37856366 Free PMC article.
A summary of the Advisory Committee for Immunization Practices (ACIP) use of a benefit-risk assessment framework during the first year of COVID-19 vaccine administration in the United States.
Wallace M, Rosenblum HG, Moulia DL, Broder KR, Shimabukuro TT, Taylor CA, Havers FP, Meyer SA, Dooling K, Oliver SE, Hadler SC, Gargano JW. Wallace M, et al. Among authors: havers fp. Vaccine. 2023 Oct 20;41(44):6456-6467. doi: 10.1016/j.vaccine.2023.07.037. Epub 2023 Jul 30. Vaccine. 2023. PMID: 37527956 Free PMC article. Review.
COVID-19-Associated Hospitalizations Among U.S. Adults Aged ≥65 Years - COVID-NET, 13 States, January-August 2023.
Taylor CA, Patel K, Patton ME, Reingold A, Kawasaki B, Meek J, Openo K, Ryan PA, Falkowski A, Bye E, Plymesser K, Spina N, Tesini BL, Moran NE, Sutton M, Talbot HK, George A, Havers FP; COVID-NET Surveillance Team. Taylor CA, et al. Among authors: havers fp. MMWR Morb Mortal Wkly Rep. 2023 Oct 6;72(40):1089-1094. doi: 10.15585/mmwr.mm7240a3. MMWR Morb Mortal Wkly Rep. 2023. PMID: 37796744 Free PMC article.
Use of Respiratory Syncytial Virus Vaccines in Adults Aged ≥60 Years: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2024.
Britton A, Roper LE, Kotton CN, Hutton DW, Fleming-Dutra KE, Godfrey M, Ortega-Sanchez IR, Broder KR, Talbot HK, Long SS, Havers FP, Melgar M. Britton A, et al. Among authors: havers fp. MMWR Morb Mortal Wkly Rep. 2024 Aug 15;73(32):696-702. doi: 10.15585/mmwr.mm7332e1. MMWR Morb Mortal Wkly Rep. 2024. PMID: 39146277 Free article.
Use of COVID-19 Vaccines for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024-2025.
Panagiotakopoulos L, Moulia DL, Godfrey M, Link-Gelles R, Roper L, Havers FP, Taylor CA, Stokley S, Talbot HK, Schechter R, Brooks O, Daley MF, Fleming-Dutra KE, Wallace M. Panagiotakopoulos L, et al. Among authors: havers fp. MMWR Morb Mortal Wkly Rep. 2024 Sep 19;73(37):819-824. doi: 10.15585/mmwr.mm7337e2. MMWR Morb Mortal Wkly Rep. 2024. PMID: 39298394 Free PMC article.
Extrapolating Sentinel Surveillance Information to Estimate National COVID Hospital Admission Rates: A Bayesian Modeling Approach.
Devine O, Pham H, Gunnels B, Reese HE, Steele M, Couture A, Iuliano D, Sachdev D, Alden NB, Meek J, Witt L, Ryan PA, Reeg L, Lynfield R, Ropp SL, Barney G, Tesini BL, Shiltz E, Sutton M, Talbot HK, Reyes I, Havers FP. Devine O, et al. Among authors: havers fp. Influenza Other Respir Viruses. 2024 Oct;18(10):e70026. doi: 10.1111/irv.70026. Influenza Other Respir Viruses. 2024. PMID: 39440677 Free PMC article.
A framework for monitoring RSV prevention product effectiveness in the United States.
Roper LE, Link-Gelles R, Surie D, DeCuir J, Zambrano LD, Prill MM, Havers FP, Jones JM, Melgar M, Hall AJ, Whitehead RD Jr, McMorrow ML, Ioannou GN, Hernandez-Romieu AC, Britton A, Novosad S, Martin A, Feldstein LR, Bajema KL, Kirking H, Moline H, Campbell AP, Aslan M, Hatfield K, Dawood F, Slayton R, Reddy S, Gomes D, Fleming-Dutra KE, Payne AB. Roper LE, et al. Among authors: havers fp. Vaccine. 2025 Jan 2;45:126633. doi: 10.1016/j.vaccine.2024.126633. Online ahead of print. Vaccine. 2025. PMID: 39755055
68 results